Alerts will be sent to your verified email
Verify Email
ONYX
|
Onyx Biotec
|
Suven Pharma
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Operational Metrics
|
|||
|
Financials
|
|||
|
5 yr Average ROE
|
14.26 % | 27.26 % | 19.44 % |
|
5yr average Equity Multiplier
|
2.82 | 1.3 | 1.5 |
|
5yr Average Asset Turnover Ratio
|
0.87 | 0.61 | 0.79 |
|
5yr Avg Net Profit Margin
|
5.93 % | 33.51 % | 16.41 % |
|
Price to Book
|
0.0 | 15.5 | 7.8 |
|
P/E
|
29.88 | 109.85 | 39.16 |
|
5yr Avg Cash Conversion Cycle
|
16.09 Days | 70.98 Days | 19.31 Days |
|
Inventory Days
|
40.2 Days | 76.62 Days | 51.72 Days |
|
Days Receivable
|
69.43 Days | 42.46 Days | 63.93 Days |
|
Days Payable
|
87.57 Days | 85.69 Days | 85.63 Days |
|
5yr Average Interest Coverage Ratio
|
5.06 | 47.81 | 65.09 |
|
5yr Avg ROCE
|
12.24 % | 32.61 % | 23.24 % |
|
5yr Avg Operating Profit Margin
|
13.24 % | 43.1 % | 23.72 % |
|
5 yr average Debt to Equity
|
1.2 | 0.09 | 0.08 |
|
5yr CAGR Net Profit
|
-1.99 % | -1.08 % | 15.23 % |
|
5yr Average Return on Assets
|
5.44 % | 20.57 % | 13.06 % |
|
Shareholdings
|
|||
|
Promoter Holding
|
65.1 % | 50.1 % | 47.84 % |
|
Share Pledged by Promoters
|
0.0 | 0.0 | 0.0 |
|
Change in Promoter Holding (3 Yrs)
|
0.0 | -9.9 % | -6.16 % |
|
Change in Mutual Fund Holding (3 Yrs)
|
0.0 | 7.13 % | 1.99 % |
|
Onyx Biotec
|
Suven Pharma
|
JB Chem & Pharma
|
|
|---|---|---|---|
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|
Product Wise Break-Up
|